Sexual dysfunction is an extremely common byproduct of breast cancer and chemotherapy. But it’s also highly-treatable with the ground-breaking FDA-approved MonaLisa Touch® CO2 fractional laser system. As a board-certified OB/GYN, health coach and advocate for women, Dr. Sharan Abdul-Rahman of Today’s Woman in Philadelphia, Pennsylvania, has helped countless breast cancer survivors reclaim healthy and satisfying sex lives following breast cancer using the MonaLisa Touch.
She said, "I'm grateful to be alive, but I'm dead down there."
She said, "Since my surgery and radiation, I've lost sensation in my breast. I used to become sexual aroused when my breasts were stroked. Now I am no longer able to have orgasms. My husband is supportive, but I miss the sexual relationship that we used to have."
She said, "The surgical reconstruction after mastectomy has not enhanced by sexuality."
Any serious illness can take a toll on your sex life. Breast cancer is no exception. The sexual side effects of breast cancer can occur just after diagnosis, during treatment and linger long after treatment has stopped. According to the National Cancer Institute, about one out of every two women who've undergone breast cancer treatment experiences long-term sexual dysfunction.
Re-thinking your sexuality is part of the solution. Non-hormonal options are available. Good sex after breast cancer is possible.
Roughly half of all survivors of breast cancer and other female cancers develop sexual problems. Most often, these are caused by cancer treatment, rather than the cancer itself.
Chemotherapy can cause hormonal changes that either temporarily or permanently put younger women into menopause. And, of course, painful intercourse and diminished libido are two of the most common symptoms of the decrease in estrogen production that accompanies menopause.
Menopausal women who haven’t had breast cancer often remedy symptoms, including vaginal dryness and thinning vaginal tissues (also known as vaginal atrophy), with hormone replacement therapy (HRT). The goal of HRT is to replicate pre-menopausal estrogen levels, thereby eliminating the symptoms caused by the natural decrease of hormones. However, most breast cancer survivors are not good candidates for HRT. That’s because about 80% are HR+ (hormone responsive positive). This means that their type of cancer requires estrogen, along with other hormones, to grow. Therefore, increasing estrogen levels is not safe.
Many patients at Today’s Woman have enjoyed excellent results and reclaimed healthy sex lives with treatment from the recently FDA-approved MonaLisa Touch CO2 fractional laser. The ground-breaking technology delivers gentle, controlled energy deep into vaginal wall tissues, via a thin wand that’s inserted into the vaginal canal. This restores vaginal health, including the ability to produce moisture, by generating new collagen, elastin, and vascularization.
This simple In-office procedure is performed by Dr.Rahman and takes only about five minutes. It’s not painful and requires no anesthesia. Though most women enjoy noticeable results after just one treatment, three treatments, scheduled six weeks apart, are recommended. After that, women need only return annually for a single maintenance treatment. The MonaLisa Touch has a better than 90% satisfaction rate.